| Ytd | 9.46% | |
| 1y | 17.29% |
| Open | 17.09 | Prev Close | 17.23 | Low | 16.99 | High | 17.21 | Mkt Cap | 54.81B |
| Vol | 532.20K | Avg Vol | 3.14M | EPS | 1.39 | P/E | 12.39 | Forward P/E | 10.60 |
| Beta | -0.07 | Short Ratio | 1.73 | Inst. Own | 3.11% | Dividend | 0.48 | Div Yield | 2.81 |
| Ex Div Date | 03-31 | Earning | 07-30 | 50-d Avg | 16.16 | 200-d Avg | 16.15 | 1yr Est | 21.05 |
TAK News
Japanese drugmaker Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's
Takeda Pharmaceutical Co. Ltd. (NYSE:TAK) on Friday revealed encouraging secondary data from two piv
Takeda shares positive Phase 3 data for its oral psoriasis drug zasocitinib, showing high skin clear
New data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly se
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced new data from
The developer of the world’s first end-to-end AI drug has projected a big leap in half-year earnings
Ministry of Health of the Republic of Indonesia Grants Plasma Fractionation License, Enabling Takeda
OSAKA, Japan & CAMBRIDGE, Mass. & JAKARTA, Indonesia--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) an
Takeda and Insilico Medicine launch a strategic AI drug discovery collaboration to identify next-gen
Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic are
Takeda is set to pay InSilico to use its proprietary Pharma. AI platform to advance drug candidates
Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology c
Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--In the final step of its 18-month CEO transition,
Once-daily oral zasocitinib demonstrated statistical superiority over deucravacitinib for all primar
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today presented additio
Silence Therapeutics says SANRECO data show sustained polycythemia vera benefits as analysts weigh d
Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced positive topl
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced the U.S
On June 01, 2026, Takeda Pharmaceutical Co Ltd (TAK) shares fell 4.8% to $15.19. The stock has faced
DNLI sinks after BIIB122 failed a mid-stage Parkinson's study, prompting Denali and Biogen to halt d
BOSTON--(BUSINESS WIRE)---- $TAK #antitrust--A class-action lawsuit regarding Amitiza ended today wh
A U.S. jury on Monday found that Takeda Pharmaceutical caused pharmacies, insurers, retailers
TAK's FY2025 revenue was about $28.4 billion, which was down 1.7% YoY due to Vyvanse's generic press
Takeda Pharmaceutical NYSE: TAK reported fiscal 2025 results that management described as solid desp
Japan's Takeda Pharmaceutical , plans to cut about 4,500 jobs in fiscal year 2026, as it pushes ahea
OSAKA, Japan--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for th
Axsome gains after securing global rights to balipodect from Takeda, advancing schizophrenia pipelin
On Friday morning, 446 companies hit new 52-week lows.
Monday saw 825 companies set new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday